跳至主要内容
临床试验/NCT02630433
NCT02630433已完成不适用

Randomised Controlled Trial of Index Cholecystectomy Versus Scheduled Cholecystectomy in Biliary Pancreatitis

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2009年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
65
试验地点
2
主要终点
Recurrent acute pancreatitis

研究概览

简要总结

There are controversies optimal timing for cholecystectomy in patients with mild biliary pancreatitis. The safety of cholecystectomy performed during an episode of pancreatitis has been questioned. The aim of the present randomized controlled trial is to compare the outcome in terms of recurrent pancreatitis and gallstone-related events between index cholecystectomy, performed during the first admission for acute pancreatitis, and scheduled cholecystectomy, performed 4-6 weeks after discharge.

详细描述

Background:

There is still considerable debate regarding the optimal timing of cholecystectomy in mild biliary pancreatitis. It is widely accepted to wait until the patient's clinical condition allows performing cholecystectomy in severe biliary pancreatitis with systemic or local complications. On the other hand, the recommendations are not very clear when it comes to patients with mild biliary pancreatitis. The British Society of Gastroenterology and American Gastroenterological Association guidelines recommendation is to perform cholecystectomy within 2-to 4- week interval after the initial episode. However, the safety of cholecystectomy performed during an episode of pancreatitis is also controversial.

In a systematic review the overall readmission rate was 18% after index cholecystectomy, 8% for recurrent biliary pancreatitis, 3 % for acute cholecystitis and 7 % for biliary colic.

Methods The study is performed as a Randomised controlled trials with two parallel arms and a ratio of 1:1. Patients admitted with acute pancreatitis are checked for eligibility criteria for the study. Mild pancreatitis is defined as pancreatitis without local complications such as necrosis or organ failure. Patients who are eligible obtained oral and written information about the study and invited to be included. Patients who accept participation sign a consent form and are included. The included patients are randomized into index cholecystectomy (IC) or scheduled cholecystectomy (SC).

Randomization is done with a sealed envelope system. The allocation sequence is created by an online random generator. There is no blocking. After randomization, the patient as well as the responsible are immediately informed about the allocation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • S-Amylase >3 microkat/L
  • One or more gallstones with diameter < 2 cm
  • S-CRP < 150 mg/L the first 24 hours

排除标准

  • Multiple organ failure
  • Solitary gallstone with diameter >2 cm
  • Concurrent cholangitis
  • Hospital stay exceeding 72 hours before screening for inclusion

研究组 & 干预措施

Index cholecystectomy

Experimental

Cholecystectomy within 48 hours after inclusion.

干预措施: Index cholecystectomy (Procedure)

Scheduled cholecystectomy

Active Comparator

Cholecystectomy 6 weeks after inclusion.

干预措施: Scheduled cholecystectomy (Procedure)

结局指标

主要结局

Recurrent acute pancreatitis

时间窗: 6 weeks

Relapse of acute pancreatitis in the scheduled cholecystectomy arm

次要结局

  • Cost-effectiveness(6 weeks)
  • Complications related to the cholecystectomy(30 days)
  • Markers of inflammatory activity(3 days)
  • Health-related quality of life measured with SF-36(6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gabriel Sandblom

Associate Professor

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验